{"id":"metrizamide","rwe":[],"tags":[{"label":"metrizamide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"V08AB01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Approved 1970s","category":"decade"},{"label":"Contrast Media","category":"pharmacology"},{"label":"Diagnostic Uses of Chemicals","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=METRIZAMIDE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:40:44.052976+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Metrizamide","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T03:40:51.114405+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:40:49.616754+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METRIZAMIDE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:40:50.055514+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL462394/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:40:50.758631+00:00"}},"allNames":"amipaque","offLabel":[],"synonyms":["metrizamide","amipaque","telebrix"],"timeline":[{"date":"1978-08-23","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"aiSummary":"Amipaque (Metrizamide) is a small molecule contrast agent in the metrizamide class, originally developed by Nyegaard & Co. It was FDA approved in 1978 for use in myelography and other imaging procedures. Amipaque is off-patent and has no active Orange Book patents, indicating it is available as a generic medication. However, there are currently no generic manufacturers listed. As a result, Amipaque remains a branded medication.","approvals":[{"date":"1978-08-23","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Amipaque","ecosystem":[],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","drugClass":"metrizamide","explanation":"","oneSentence":"","technicalDetail":"Amipaque is a non-ionic, water-soluble contrast agent that is selectively taken up by cells in the central nervous system, primarily through a process involving the glucose transporter protein. This selective uptake allows for high-contrast imaging of the spinal cord and surrounding structures, while minimizing the risk of toxicity to other tissues."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Metrizamide","title":"Metrizamide","extract":"Metrizamide is a non-ionic iodine-based radiocontrast agent. It is also a density gradient medium for the centrifugation of biological particles.","wiki_history":"== History ==\nMetrizamide was approved in the US in 1978. Its marketing is discontinued as of 2021."},"commercial":{"launchDate":"1978","_launchSource":"DrugCentral (FDA 1978-08-23, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1788","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METRIZAMIDE","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Metrizamide","fields":["history","overview"],"source":"Wikipedia"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:03:00.810975","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:40:52.385476+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"iohexol","drugSlug":"iohexol","fdaApproval":"1985-12-26","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ioxaglic acid","drugSlug":"ioxaglic-acid","fdaApproval":"1985-07-26","relationship":"same-class"},{"drugName":"iopamidol","drugSlug":"iopamidol","fdaApproval":"1985-12-31","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"iopromide","drugSlug":"iopromide","fdaApproval":"1995-05-10","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"iotrolan","drugSlug":"iotrolan","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"ioversol","drugSlug":"ioversol","fdaApproval":"1988-12-30","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"iodixanol","drugSlug":"iodixanol","fdaApproval":"1996-03-22","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ioxilan","drugSlug":"ioxilan","fdaApproval":"1995-12-21","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"metrizamide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"iohexol","brandName":"iohexol","genericName":"iohexol","approvalYear":"1985","relationship":"same-class"},{"drugId":"ioxaglic-acid","brandName":"ioxaglic acid","genericName":"ioxaglic acid","approvalYear":"1985","relationship":"same-class"},{"drugId":"iopamidol","brandName":"iopamidol","genericName":"iopamidol","approvalYear":"1985","relationship":"same-class"},{"drugId":"iopromide","brandName":"iopromide","genericName":"iopromide","approvalYear":"1995","relationship":"same-class"},{"drugId":"iotrolan","brandName":"iotrolan","genericName":"iotrolan","approvalYear":"","relationship":"same-class"},{"drugId":"ioversol","brandName":"ioversol","genericName":"ioversol","approvalYear":"1988","relationship":"same-class"},{"drugId":"iodixanol","brandName":"iodixanol","genericName":"iodixanol","approvalYear":"1996","relationship":"same-class"},{"drugId":"ioxilan","brandName":"ioxilan","genericName":"ioxilan","approvalYear":"1995","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000146557","MMSL":"464","NDDF":"002350","UNII":"RHH3W8F1CO","VUID":"4018226","CHEBI":"CHEBI:31841","VANDF":"4018226","INN_ID":"3116","RXNORM":"6920","UMLSCUI":"C0025869","chemblId":"CHEMBL462394","ChEMBL_ID":"CHEMBL462394","KEGG_DRUG":"D01311","DRUGBANK_ID":"DB01578","PUBCHEM_CID":"443944","SNOMEDCT_US":"414693007","MESH_DESCRIPTOR_UI":"D008793","MESH_SUPPLEMENTAL_RECORD_UI":"C002587"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2201,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"V08AB01","allCodes":["V08AB01"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1978","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1978-08-23T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:40:52.385476+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":false,"score":0}}